OraLiva
Durham, US · Delaware corporation · 1 known investors
OraLiva provides an AI-powered brush biopsy test for early oral cancer and dysplasia detection in dental settings. The minimally-invasive chairside test delivers clinically-validated results within days to help dentists identify disease and support patient outcomes.
Founders & leadership
AG
Anna GrassiniExecutive Officer, Director
JM
John McDevittDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$1.5MraisedMar 2025 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedMar 2025 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anna GrassiniExecutive Officer, Director
- John McDevittDirector
- Offering amount
- $2.3M
- Amount sold
- $1.5M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.